Nom du produit:N-(1,3-dimethyl-2,2-dioxo-1,3-dihydro-2lambda6,1,3-benzothiadiazol-5-yl)quinoxaline-2-carboxamide
IUPAC Name:N-(1,3-dimethyl-2,2-dioxo-1,3-dihydro-2λ⁶,1,3-benzothiadiazol-5-yl)quinoxaline-2-carboxamide
- CAS:2034587-02-3
- Formule moléculaire:C17H15N5O3S
- Pureté:95%+
- Numéro de catalogue:CM936045
- Poids moléculaire:369.4
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2034587-02-3
- Formule moléculaire:C17H15N5O3S
- Point de fusion:-
- Code SMILES:CN1C2=C(C=C(NC(=O)C3=CN=C4C=CC=CC4=N3)C=C2)N(C)S1(=O)=O
- Densité:
- Numéro de catalogue:CM936045
- Poids moléculaire:369.4
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.